
### [NCIT:C3359](http://purl.obolibrary.org/obo/NCIT_C3359)
**Label:** Rhabdomyosarcoma

**Subclasses:** [NCIT:C5525](http://purl.obolibrary.org/obo/NCIT_C5525) (Prostate Embryonal Rhabdomyosarcoma), [NCIT:C6617](http://purl.obolibrary.org/obo/NCIT_C6617) (Mediastinal Rhabdomyosarcoma), [NCIT:C5847](http://purl.obolibrary.org/obo/NCIT_C5847) (Extrahepatic Bile Duct Embryonal Rhabdomyosarcoma), [NCIT:C5627](http://purl.obolibrary.org/obo/NCIT_C5627) (Rectal Rhabdomyosarcoma), [NCIT:C5522](http://purl.obolibrary.org/obo/NCIT_C5522) (Prostate Rhabdomyosarcoma), [NCIT:C4258](http://purl.obolibrary.org/obo/NCIT_C4258) (Pleomorphic Rhabdomyosarcoma), [NCIT:C4259](http://purl.obolibrary.org/obo/NCIT_C4259) (Rhabdomyosarcoma with Mixed Embryonal and Alveolar Features), [NCIT:C6378](http://purl.obolibrary.org/obo/NCIT_C6378) (Testicular Rhabdomyosarcoma), [NCIT:C5464](http://purl.obolibrary.org/obo/NCIT_C5464) (Central Nervous System Rhabdomyosarcoma), [NCIT:C8971](http://purl.obolibrary.org/obo/NCIT_C8971) (Embryonal Rhabdomyosarcoma), [NCIT:C5860](http://purl.obolibrary.org/obo/NCIT_C5860) (Extrahepatic Bile Duct Rhabdomyosarcoma), [NCIT:C49204](http://purl.obolibrary.org/obo/NCIT_C49204) (Anaplastic Embryonal Rhabdomyosarcoma), [NCIT:C123735](http://purl.obolibrary.org/obo/NCIT_C123735) (Fusion-Positive Rhabdomyosarcoma), [NCIT:C123736](http://purl.obolibrary.org/obo/NCIT_C123736) (Fusion-Negative Rhabdomyosarcoma), [NCIT:C123731](http://purl.obolibrary.org/obo/NCIT_C123731) (Fusion-Positive Alveolar Rhabdomyosarcoma), [NCIT:C5190](http://purl.obolibrary.org/obo/NCIT_C5190) (Breast Rhabdomyosarcoma), [NCIT:C9130](http://purl.obolibrary.org/obo/NCIT_C9130) (Adult Rhabdomyosarcoma), [NCIT:C123732](http://purl.obolibrary.org/obo/NCIT_C123732) (Fusion-Negative Alveolar Rhabdomyosarcoma), [NCIT:C121655](http://purl.obolibrary.org/obo/NCIT_C121655) (Sclerosing Rhabdomyosarcoma), [NCIT:C95623](http://purl.obolibrary.org/obo/NCIT_C95623) (Esophageal Rhabdomyosarcoma), [NCIT:C121654](http://purl.obolibrary.org/obo/NCIT_C121654) (Spindle Cell/Sclerosing Rhabdomyosarcoma), [NCIT:C127058](http://purl.obolibrary.org/obo/NCIT_C127058) (Uterine Corpus Rhabdomyosarcoma), [NCIT:C128048](http://purl.obolibrary.org/obo/NCIT_C128048) (Cervical Rhabdomyosarcoma), [NCIT:C6519](http://purl.obolibrary.org/obo/NCIT_C6519) (Spindle Cell Rhabdomyosarcoma), [NCIT:C3749](http://purl.obolibrary.org/obo/NCIT_C3749) (Alveolar Rhabdomyosarcoma), [NCIT:C5834](http://purl.obolibrary.org/obo/NCIT_C5834) (Liver Rhabdomyosarcoma), [NCIT:C128080](http://purl.obolibrary.org/obo/NCIT_C128080) (Vaginal Rhabdomyosarcoma), [NCIT:C8824](http://purl.obolibrary.org/obo/NCIT_C8824) (Recurrent Rhabdomyosarcoma), [NCIT:C5610](http://purl.obolibrary.org/obo/NCIT_C5610) (Anal Rhabdomyosarcoma), [NCIT:C5236](http://purl.obolibrary.org/obo/NCIT_C5236) (Ovarian Rhabdomyosarcoma), [NCIT:C27369](http://purl.obolibrary.org/obo/NCIT_C27369) (Adult Pleomorphic Rhabdomyosarcoma), [NCIT:C45759](http://purl.obolibrary.org/obo/NCIT_C45759) (Cardiac Rhabdomyosarcoma), [NCIT:C128273](http://purl.obolibrary.org/obo/NCIT_C128273) (Vulvar Alveolar Rhabdomyosarcoma), [NCIT:C5839](http://purl.obolibrary.org/obo/NCIT_C5839) (Gallbladder Rhabdomyosarcoma), 

**Class expressions from DL-Learner:**

- [NCIT:C36103](http://purl.obolibrary.org/obo/NCIT_C36103) (Rapidly Enlarging Mass) 75.00%
- Thing 50.92%
- [NCIT:C49198](http://purl.obolibrary.org/obo/NCIT_C49198) (Malignant Rhabdomyoblast) 47.36%
- [NCIT:C49197](http://purl.obolibrary.org/obo/NCIT_C49197) (Malignant Skeletal Muscle Cell) 45.41%
- [NCIT:C49167](http://purl.obolibrary.org/obo/NCIT_C49167) (Neoplastic Skeletal Muscle Cell) 43.90%
- [NCIT:C36744](http://purl.obolibrary.org/obo/NCIT_C36744) (Rhabdomyoblast) 42.68%
- [NCIT:C36947](http://purl.obolibrary.org/obo/NCIT_C36947) (Neoplastic Striated Muscle Cell) 40.81%
- [NCIT:C36936](http://purl.obolibrary.org/obo/NCIT_C36936) (Neoplastic Muscle Cell) 37.13%
- [NCIT:C48787](http://purl.obolibrary.org/obo/NCIT_C48787) (Malignant Connective and Soft Tissue Cell) 33.70%
- [NCIT:C36887](http://purl.obolibrary.org/obo/NCIT_C36887) (Neoplastic Connective and Soft Tissue Cell) 30.59%
- [NCIT:C36843](http://purl.obolibrary.org/obo/NCIT_C36843) (Abnormal Connective and Soft Tissue Cell) 30.42%
- [NCIT:C12917](http://purl.obolibrary.org/obo/NCIT_C12917) (Malignant Cell) 28.23%
- [NCIT:C12922](http://purl.obolibrary.org/obo/NCIT_C12922) (Neoplastic Cell) 27.48%
- [NCIT:C12913](http://purl.obolibrary.org/obo/NCIT_C12913) (Abnormal Cell) 27.36%
- [NCIT:C3367](http://purl.obolibrary.org/obo/NCIT_C3367) (Finding) 26.78%


